SureTrader
Interactive Brokers Advertisement
Home > Boards > US OTC > Medical - Drugs >

Elite Pharmaceuticals (ELTP)

ELTP RSS Feed
Add ELTP Price Alert      Hide Sticky   Hide Intro
Moderator: Drugdoctor, dr_lowenstein, lasers, NASDAQ2020, IB_, Chasing
Search This Board: 
Last Post: 11/23/2017 11:45:26 AM - Followers: 835 - Board type: Free - Posts Today: 17

Elite Pharmaceuticals, Inc. (ELTP)

 
About Elite Pharmaceuticals
 
Elite Pharmaceuticals is a specialty pharmaceutical company specializing in niche generics and committed to the development of abuse-deterrent opioids to help curb diversion, misuse and abuse.  Elite has a pipeline of opioid abuse-deterrent products under development utilizing the company’s proprietary pharmacological abuse-deterrent technology. 
 
Located in Northvale, New Jersey, Elite operates a 55,000 square foot campus under Current Good Manufacturing Practice (“cGMP”) and is a United States Drug Enforcement Agency (“DEA”) registered facility for research, development, manufacturing and packaging of pharmaceutical products.
 
More information including Elite’s proprietary Abuse Resistant Technology can be found at http://www.elitepharma.com
 


About Elite's Abuse Deterrent Technology

Elite's abuse deterrent products utilize the Company's proprietary pharmacological abuse deterrent technology. Elite's abuse deterrent technology is a multi-particulate capsule which contains an opioid agonist in addition to naltrexone, an opioid antagonist. Naltrexone is an opioid receptor antagonist used primarily in the management of alcohol dependence and opioid dependence. When this product is taken as intended, the naltrexone is designed to pass through the body unreleased while the opioid agonist releases over time providing therapeutic pain relief for which it is prescribed. If the multi-particulate beads are crushed, the opioid antagonist, naltrexone, is designed to release. The absorption of the naltrexone is intended to block the euphoria by preferentially binding to same receptors in the brain as the opioid agonist and thereby reducing the incentive for abuse or misuse by recreational drug abusers.
 
Elite continues to expands the intellectual property for the Company's opioid abuse deterrent technology. Elite now has four US patents, one European patent, and two Canadian patents issued in this area with additional patents pending in the U.S., Canada and Europe.
 
Products & Pipeline
 
Screen%20Shot%202017-05-28%20at%2011.53.29%20AM.png
 
Elite’s principle product is SequestOx, an immediate-release oxycodone with sequestered naltrexone abuse-deterrent opioid product for the management of moderate to severe acute pain. Additional products include bariatric, cardiovascular, antihistamine, skeletal muscle relaxants, antipsychotic, tricyclic antidepressant, along with a number of approved products pending manufacturing site transfer.
 
Elite owns generic and OTC products which have been licensed to TAGI Pharma, Epic Pharma, Dr. Reddy's Laboratories and Valeant Pharmaceuticals International. Additional information regarding Elite’s wholly owned products, partnerships, and contract manufacturing can be found at  http://www.elitepharma.com/products
 
The list of pipeline products can be found at http://www.elitepharma.com/pipeline-generics
 
Leadership
 
Nasrat Hakim, Chairman, President & Chief Executive Officer
 
Nasrat Hakim joined Elite in August 2013 as Director, President and Chief Executive Officer. Mr. Hakim has more than 30 years of pharmaceutical and medical industry experience in Quality Assurance, Analytical Research and Development, Technical Services and Regulatory Compliance. He brings with him proven management experience, in-depth knowledge of manufacturing systems, development knowledge in immediate and extended release formulations and extensive regulatory experience of GMP and FDA regulations. Prior to his leading Elite, from 2004 to 2013, Mr. Hakim was employed by Actavis, Watson and Alpharma in various senior management positions. Most recently, Mr. Hakim served as International Vice President of Quality Assurance at Actavis, overseeing 25 sites with more than 3,000 employees under his leadership.  Mr. Hakim also served as Corporate Vice President of Technical Services, Quality and Regulatory Compliance for Actavis U.S., Global Vice President, Quality and Regulatory Compliance for Alpharma, as well as Executive Director of Quality Unit at TheraTech, overseeing manufacturing and research and development. In 2009, Mr. Hakim founded Mikah Pharma, LLC, a virtual, fully functional pharmaceutical company. 

Mr. Hakim’s career started in Medical Laboratory Technology from the Academy of Health and Sciences in the U.S. Army based in San Antonio, TX, followed by Graduate Certification in Regulatory Affairs (RAC) from California State University at Sacramento, Sacramento, CA; Bachelor in Chemistry/Bio-Chemistry and Masters of Science in Chemistry from California State University at Sacramento, Sacramento, CA; and a Masters in Law with Graduate Certification in U.S. Taxation from St. Thomas University, School of Law, Miami, FL.
 

Investor Relations and Corporate Inquiries

Dianne Will
Vice President of Investor Relations and Corporate Affairs
Telephone: 518-398-6222
Email: 
dianne@elitepharma.com

Corporate Headquarters
165 Ludlow Avenue
Northvale, New Jersey 07647
Phone: 201-750-2646
Fax: 201-750-2755


 

Miscellaneous Links:
 
Elite Pharmaceuticals News
http://ir.elitepharma.com/press_releases
 
SEC Filings
http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001053369&owner=include

FDA website
http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.DrugDetails

Clinical Trials.Gov
https://www.clinicaltrials.gov/
 
Yahoo Finance
https://finance.yahoo.com/quote/ELTP/?p=ELTP
 
Seeking Alpha
https://seekingalpha.com/symbol/ELTP
 

ELTP Daily Chart
    


SureTrader
Interactive Brokers Advertisement
ELTP
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ELTP News: Current Report Filing (8-k) 11/09/2017 05:05:42 PM
ELTP News: Quarterly Report (10-q) 11/09/2017 04:53:40 PM
ELTP News: Confidential Treatment Order (ct Order) 10/11/2017 12:26:51 PM
ELTP News: Current Report Filing (8-k) 09/07/2017 04:32:57 PM
ELTP News: Current Report Filing (8-k) 08/09/2017 05:01:18 PM
PostSubject
#277171  Sticky Note Links for November 10th Conference Call transcript/replay Chasing 11/12/17 01:57:56 PM
#275620  Sticky Note Let's talk Nasrat's "Strategy" for a minute. Play Mazeppa 10/30/17 01:49:46 PM
#274770  Sticky Note memorable "calls" for elite pharma: dr_lowenstein 10/24/17 04:09:11 PM
#271038  Sticky Note Elite Pharma at Pain Week 2017 NASDAQ2020 09/17/17 04:03:01 PM
#234937  Sticky Note THIS IS WHAT YOU NEED TO KNOW BEFORE Couch 11/30/16 03:04:07 PM
#189564  Sticky Note $ELTP SequestOx and ADF Patents lasers 03/18/16 04:29:26 AM
#185967  Sticky Note The only topic here is ELTP. IH Dan (Retired) 02/23/16 09:32:46 PM
#278331   Zen, and when you are happy with your sharkey1 11/23/17 11:49:49 AM
#278330   you only have one life sharkey1 11/23/17 11:45:26 AM
#278329   Nothing is going on and there in lies stockboy 11/23/17 11:37:15 AM
#278328   Of course he’s dumping daily through LPC. No stockboy 11/23/17 11:36:08 AM
#278327   OK just checked the FDA website I’ve been rocioyogi 11/23/17 10:54:12 AM
#278321   Happy Thanksgiving to all Elite investors AND to no2koolaid 11/23/17 09:02:59 AM
#278320   Well it's Thanksgiving, again, next week we head sharkey1 11/23/17 08:41:54 AM
#278319   Happy turkey day all!!!! steve9465 11/23/17 07:49:32 AM
#278318   TO all members of the IHUB community and namtae 11/23/17 07:42:56 AM
#278317   Form 4's aren't required to sell shares to jour_trader 11/23/17 07:11:58 AM
#278316   Totally BS. Show me the form 4!!! Oh YJ4LIFE 11/23/17 04:25:48 AM
#278313   I just got in and seen that Elite IB_ 11/22/17 05:47:33 PM
#278312   HAPPY THANKS GIVING to everyone! stockboy 11/22/17 04:21:56 PM
#278311   NasRAT unloading shares below .10 sounds like a stockboy 11/22/17 04:19:56 PM
#278310   We heard that the SequesTOX wasn't dead after stockboy 11/22/17 04:18:16 PM
#278309   I was told it was going down to newguy11 11/22/17 04:06:55 PM
#278308   I knew it wouldn't be filled. I barttrab11 11/22/17 04:05:01 PM
#278306   Thankful for all of you here. Though we are Dubster watching 11/22/17 03:45:13 PM
#278305   I know it's crazy I can't even get newguy11 11/22/17 03:35:56 PM
#278304   Yep! They both want in on the China sharkey1 11/22/17 03:17:39 PM
#278303   I blame Russia and North Korea. jour_trader 11/22/17 02:59:49 PM
#278302   AS well you also. Have a great thanksgiving. lasers 11/22/17 02:54:56 PM
#278301   Strange!!, have a good thank's giving and thanks sharkey1 11/22/17 02:48:55 PM
#278300   Yes it is back again lasers 11/22/17 02:45:29 PM
#278299   Almost a 10 to 1 sells to buy BostonTrader 11/22/17 02:44:19 PM
#278298   Newguy-The one sure clue there will be a mts 11/22/17 02:43:58 PM
#278297   Same BS as approval was sequestox was a BostonTrader 11/22/17 02:41:55 PM
#278296   OK rocio,you can pass up the mission, we sharkey1 11/22/17 02:19:10 PM
#278295   Everybody have a great Thanksgiving and I hope rocioyogi 11/22/17 02:17:14 PM
#278294   Well if I did still partake I would rocioyogi 11/22/17 02:15:13 PM
#278293   Its completely correct and hits the mark, and newguy11 11/22/17 02:00:24 PM
#278292   That's where it was yesterday too, now sharkey1 11/22/17 01:59:29 PM
#278291   Well said... namtae 11/22/17 01:59:29 PM
#278290   Thats completely wrong and misses the mark namtae 11/22/17 01:55:34 PM
#278289   I just did Jour, same browser I used sharkey1 11/22/17 01:54:36 PM
#278288   It’s on page 6 at the top I rocioyogi 11/22/17 01:53:51 PM
#278287   My guess is that it is more of jour_trader 11/22/17 01:49:36 PM
#278286   Lasers, now it's back, FREAKY, sharkey1 11/22/17 01:40:41 PM
#278285   Truth !!!! IB_ 11/22/17 01:23:52 PM
#278284   as a long time, experienced, savvy manager that dr_lowenstein 11/22/17 01:17:31 PM
#278283   Actually, there are the revenues Elite has generated no2koolaid 11/22/17 01:10:15 PM
#278282   OK, thanks lasers, I thought I was sharkey1 11/22/17 01:00:13 PM
#278281   Elite has been taken off-line again lasers 11/22/17 12:51:57 PM
#278280   Once SequestOx is approved it will be the NASDAQ2020 11/22/17 11:38:35 AM
#278279   I still don't see it, must be my PC sharkey1 11/22/17 11:36:56 AM
#278278   THX, it came back sharkey1 11/22/17 11:31:49 AM
#278277   It’s there, third from the bottom AMR3 11/22/17 11:28:06 AM
#278276   Elite has disappeared again, not on page 5 sharkey1 11/22/17 11:02:46 AM
#278275   Looks like what you would expect from a dr_lowenstein 11/22/17 10:57:10 AM
#278273   We could get a P/R today, UPS and sharkey1 11/22/17 10:50:04 AM
PostSubject